Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Nov 2024 for Celldex Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleJames J. Marino
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
James J. Marino: trading record in brief
Filings by James J. Marino span 2 companies, the busiest being Celldex Therapeutics, Inc. and Traws Pharma, Inc. In total, 2 filings cover trades dated from 28 September 2021 to 18 November 2024.
The open-market record is one-sided, with 1 purchase worth €21k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 20 November 2024 with a transaction in Celldex Therapeutics, Inc. The most recent open-market purchase was published on 28 September 2021, 1,846 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James J. Marino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,500 shares0Common StockSEC:0001415889-24-027329:0
5,952 shares@ US$4.20100.0% of flowCommon StockSEC:0001179110-21-008955:0
Canonical exit: 27 Dec 2021 (T+90)
2 of 2 declarations
